Safeguarding the long-term health of hematopoietic stem cell donors: a continuous and evolving process to maintain donor safety and trust

Effects of granulocyte-colony stimulating factor on chromosome aneuploidy and replication asynchrony in healthy peripheral blood stem cell donors

(2011) B. Hirsch et al.   BLOOD

Concerns about the use of biosimilar granulocyte colony-stimulating factors for the mobilization of stem cells in normal donors: position of the World Marrow Donor Association

(2011) B. E. Shaw et al.   HAEMATOLOGICA

Congenital neutropenia: diagnosis, molecular bases and patient management

(2011) Jean Donadieu et al.   Orphanet Journal of Rare Diseases

Practice patterns for evaluation, consent, and care of related donors and recipients at hematopoietic cell transplantation centers in the United States

(2010) P. V. O'Donnell et al.   BLOOD

Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program

(2009) M. A. Pulsipher et al.   BLOOD

Recovery and Safety Profiles of Marrow and PBSC Donors: Experience of the National Marrow Donor Program

(2008) John P. Miller et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction

(2008) S. M. Devine et al.   BLOOD

The US National Marrow Donor Program role in unrelated donor hematopoietic cell transplantation

(2008) D Confer et al.   BONE MARROW TRANSPLANTATION

Hematopoietic growth factors-use in normal blood and stem cell donors: clinical and ethical issues

(2008) Jeffrey McCullough et al.   TRANSFUSION